Delek US
DK
$75.79
-3.11%
Delek US Holdings, Inc. is an integrated downstream energy company operating independent crude oil refineries that produce gasoline, diesel, jet fuel, and asphalt for transportation and industrial markets, complemented by a logistics segment that gathers, transports, stores, and markets crude and refined products, and a retail convenience-store network concentrated in the Southeast. The company is a mid-cap, regionally focused refiner rather than a diversified major — its competitive identity rests on inland, landlocked Gulf Coast and Permian-adjacent refining assets with crude optionality, plus a majority economic interest in the publicly traded Delek Logistics master limited partnership that provides a fee-based earnings ballast against volatile refining margins. The current investor narrative is a violent cyclical earnings recovery: after a deeply loss-making 2024 and a weak first half of 2025, crack spreads and jet fuel margins have inflected sharply, driving a second-quarter 2026 earnings surge and a stock that has more than doubled over the past year, with management commentary and sell-side coverage framing further upside around margin capture, logistics dropdowns, and capital returns. Debate now centers on whether the margin windfall is durable or peak-cycle, how much of the rally is already discounted, and whether the elevated leverage and thin equity base can support the dividend and buyback while funding turnaround capital spending.…
DK
Delek US
$75.79
Related headlines
People also watch
Valero Energy
VLO
Marathon Petroleum
MPC
Phillips 66
PSX
HF Sinclair Corporation
DINO
PBF Energy
PBF
Investment Opinion: Should I buy DK Today?
We rate DK a Hold. The core thesis is that the company has executed a remarkable cyclical recovery, but the easy money has been made; the stock trades near its 52-week high with only 5.4% upside to the average analyst target of $80.69, while significant leverage and margin uncertainty limit further multiple expansion. The consensus 'buy' rating (mean 2.23) and high target of $97 reflect optimism, but we see a balanced risk/reward at current levels.
Supporting evidence includes the 47.83% YoY revenue growth in Q2 2026 to $4.087 billion, a swing to $169.5 million net income (EPS $2.76), and robust TTM free cash flow of $684.9 million. Valuation on EV/EBITDA (5.79x) and forward PE (8.02x) is undemanding relative to the broader market, and the PS ratio of 0.168x is near the low end of its historical range. However, the debt-to-equity of 11.70x and current ratio of 0.818 are red flags that cap the upside. The dividend yield of 3.44% is attractive but its sustainability is questionable given the negative payout ratio.
The biggest risks that could invalidate the thesis are a sharp decline in crack spreads, a liquidity crunch from high leverage, and a dividend cut. We would upgrade to Buy if the stock pulls back to the $60s (near the analyst low target) while margins remain stable, or if debt-to-equity falls below 8x through asset sales or debt reduction. We would downgrade to Sell if gross margins fall below 5% for two consecutive quarters or if the dividend is cut. Relative to its own history and peers, DK appears fairly valued on cash flow but expensive on book value; the stock is not overvalued, but it is no longer deeply undervalued after the rally.
Sign up to view all
DK 12-Month Price Forecast
Delek has staged an impressive turnaround, but the stock now trades near its 52-week high and close to the analyst average target, suggesting the recovery is largely priced in. The valuation on cash flow metrics remains attractive, but the extreme leverage and cyclicality of refining margins pose significant risks. We are neutral with medium confidence: the base case (50% probability) sees the stock range-bound around $75-85 as margins moderate but remain healthy. We would upgrade to bullish if the company demonstrates sustained margin strength and reduces leverage, or if the stock pulls back to the $60s. We would downgrade to bearish if crack spreads collapse or if liquidity concerns emerge.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Delek US's 12-month outlook, with a consensus price target around $84.85 and implied upside of +11.9% versus the current price.
Average Target
$84.85
0 analysts
Implied Upside
+11.9%
vs. current price
Analyst Count
—
covering this stock
Price Range
$62 - $118
Analyst target range
Coverage is solid for a mid-cap refiner, with 13 analysts and a consensus recommendation of "buy" (mean rating of 2.23 on a scale where lower is more bullish). The average target price of $80.69 implies roughly +5.4% upside from the current $76.59, a modest gap that suggests the sell-side views the stock as fairly valued after its run rather than materially undervalued. The consensus leans constructive but not aggressive — consistent with a stock that has already delivered a 132% one-year return and now trades near 90% of its 52-week range, leaving analysts to justify incremental upside on margin durability rather than multiple re-rating.
The target range of $58.00 to $97.00 is wide — a 67% spread from low to high — signaling genuine disagreement about the sustainability of refining margins. The $97 high target implies multiple expansion and sustained crack spreads near recent levels, effectively capitalizing the Q2 EBITDA run-rate; the $58 low target prices in margin normalization and a return toward the August consolidation lows around $59.75. Institutional ratings show a stable-to-positive tilt: Raymond James, TD Cowen, Wells Fargo, Goldman Sachs, and Mizuho all maintain Outperform/Buy/Overweight ratings through September 2026, while Morgan Stanley and JP Morgan remain Equal Weight/Neutral — a split that mirrors the bull-bear debate over peak-cycle earnings. Notably, there have been no downgrades in the recent ratings history, and the absence of fresh upgrades alongside a flat one-month price suggests the analyst community is in a holding pattern awaiting the next earnings print to validate or refute the margin thesis.
Drowning in data?
Find the real signal!
Bulls vs Bears: DK Investment Factors
The bull case rests on a powerful cyclical recovery, with Q2 2026 EPS of $2.76 and $684.9 million in TTM free cash flow demonstrating the earnings power of Delek's refining assets. Valuation on EV/EBITDA (5.79x) and forward PE (8.02x) remains undemanding, and the logistics segment provides a growing fee-based cushion. However, the bear case is equally compelling: debt-to-equity of 11.70x, a current ratio below 1, and a trailing net margin of -0.21% reveal a fragile balance sheet that depends on sustained crack spreads. The stock's 132% one-year rally has pushed it to near the 52-week high, leaving only 5.4% upside to the average analyst target. The single most important tension is the durability of refining margins: if Q2's 8.93% gross margin proves to be peak-cycle, the equity could retrace sharply toward the $58 low target; if margins hold, the forward multiple suggests further upside. Currently, the bear evidence on leverage and valuation appears slightly stronger, warranting a cautious stance.
Bullish
- Explosive earnings recovery: Q2 2026 net income of $169.5 million (EPS $2.76) reversed a -$201.3 million loss in Q1 2026 and a -$106.4 million loss in Q2 2025, driven by a 47.83% YoY revenue surge to $4.087 billion. This demonstrates the powerful operating leverage inherent in Delek's refining model when crack spreads inflect.
- Deeply discounted cash-flow multiples: EV/EBITDA of 5.79x and PS of 0.168x are at the low end of the independent refiner range, implying the market is not extrapolating the Q2 EBITDA run-rate. The forward PE of 8.02x and PEG of 0.816 suggest the recovery is being priced at a discount to its growth.
- Strong free cash flow generation: TTM free cash flow of $684.9 million and Q2 2026 FCF of $84.1 million after $173.8 million capex comfortably cover the $15.6 million quarterly dividend and $20 million buyback. This supports capital returns and deleveraging if margins hold.
- Logistics segment provides stable cash flow: The logistics segment generated $384.7 million in Q2 2026 revenue and, through Delek Logistics, provides fee-based earnings that act as a ballast against volatile refining margins. The recent dividend hike at Delek Logistics underscores its cash-generation capacity.
Bearish
- Extreme leverage and thin equity base: Debt-to-equity of 11.70x, total debt-to-capitalization of 88.5%, and a current ratio of 0.818 highlight a precarious balance sheet. With Q2 interest expense of $100.1 million, the company is highly sensitive to margin downturns and refinancing risk.
- Cyclical earnings and margin volatility: Gross margin swung from -2.66% in Q1 2026 to 8.93% in Q2 2026, and trailing net margin is still -0.21%. The forward PE of 8.02x is a bet on sustained crack spreads, not a durable earnings base, and the stock's -36.02% max drawdown illustrates the downside risk.
- Valuation near 52-week high after huge rally: The stock has surged 131.95% over the past year and 157.19% YTD, trading at $76.59, or 90.1% of its 52-week range. The average analyst target of $80.69 offers only 5.4% upside, suggesting much of the recovery is already priced in.
- Recent momentum deceleration: The stock is down 3.25% over the past month versus a 1.22% gain for the S&P 500, producing a relative strength of -4.47%. This divergence, following a parabolic advance, signals potential consolidation or distribution.
DK Technical Analysis
Delek is in a powerful, sustained uptrend: the stock has gained 131.95% over the past year and 157.19% year-to-date, massively outperforming the S&P 500's 15.53% and 11.93% respective returns, with relative strength of +116.42% over twelve months and +145.26% YTD. At $76.59, the shares sit at roughly 90.1% of the 52-week range of $25.85 to $82.27 — near the top of the band but not at the extreme, which signals strong trend momentum with some room before overextension becomes a mechanical concern. The 52-week low of $25.85 underscores how far the stock has traveled; buyers near that level captured a nearly threefold move, and the current positioning implies the market has already repriced the earnings recovery rather than merely anticipating it.
Short-term momentum is decelerating even as the longer-term trend remains intact. The stock is down 3.25% over the past month versus a +1.22% gain for the S&P 500, producing a relative strength reading of -4.47% for the one-month window — a clear divergence from the +21.09% three-month and +105.72% six-month gains (versus +2.69% and +7.48% for SPY). This pattern — parabolic multi-month advance followed by a flat-to-lower month — is characteristic of consolidation after a momentum spike rather than an outright reversal, particularly given the stock's 0.602 beta, which implies roughly 40% less volatility than the market and argues against reading the pullback as distribution. The recent sequence from the September 17 high of $81.55 down to $66.91 on September 24 and back to $76.59 shows a sharp shakeout that has been largely recovered, with the last print down only 0.38% on the day.
Key technical levels are well defined: resistance sits at the 52-week high of $82.27, with the September 17 intraday-area close of $81.55 as the immediate ceiling, while support clusters at the September 24 close of $66.91 and, more structurally, the 52-week low of $25.85. A decisive breakout above $82.27 would confirm the uptrend's continuation and likely force momentum and trend-following funds to add exposure; a breakdown below $66.91 would signal a failed breakout and open the door to a deeper mean-reversion toward the $60 area where the stock consolidated in August. With a beta of 0.602 and a maximum drawdown of -36.02% over the measured period, position sizing should account for a stock that is less market-sensitive than the index but still capable of sharp, news-driven gaps — the August 5 drop from $66.20 to $59.75 is a reminder of event risk around earnings and margin headlines.
Beta
0.60
0.60x market volatility
Max Drawdown
-36.0%
Largest decline past year
52-Week Range
$26-$82
Price range past year
Annual Return
+113.1%
Cumulative gain past year
| Period | DK Return | S&P 500 |
|---|---|---|
| 1m | +3.3% | -1.2% |
| 3m | +19.9% | +3.4% |
| 6m | +91.1% | +7.0% |
| 1y | +113.1% | +14.4% |
| ytd | +154.5% | +12.0% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
DK Fundamental Analysis
Revenue is inflecting sharply upward after a prolonged trough. Second-quarter 2026 revenue reached $4.087 billion, up 47.83% year-over-year from $2.7646 billion in Q2 2025, and up 54% sequentially from Q1 2026's $2.6531 billion — a genuine acceleration rather than a stabilization. The refining segment dominates the mix at $4.056 billion versus $384.7 million for logistics, so the top-line surge is overwhelmingly a crack-spread and throughput story rather than a structural mix shift; the sequential revenue jump from $2.43 billion in Q4 2025 to $4.09 billion in Q2 2026 tracks the margin recovery narrative and implies the investment case remains highly levered to refining economics rather than the steadier logistics cash flows.
Profitability has swung from deeply negative to solidly positive. Q2 2026 net income was $169.5 million (EPS $2.76 diluted, $2.71), a dramatic reversal from the -$201.3 million loss in Q1 2026 and the -$106.4 million loss in Q2 2025, with gross profit of $365.1 million and a gross margin of 8.93% versus a negative -2.66% gross margin in the prior quarter. Operating income of $302.4 million (7.40% operating margin) and EBITDA of $621.5 million (15.21% EBITDA margin) confirm the operating leverage inherent in refining, while the trailing net margin of -0.21% and gross margin of 5.30% show how thin the full-year picture remains despite the blowout quarter. The margin profile is typical of independent refiners — single-digit gross margins are structural, not a red flag — but the swing from -2.66% to 8.93% in one quarter illustrates why earnings here are cyclical and why the forward PE of 8.02x is a bet on sustained crack spreads rather than a durable earnings base.
Balance-sheet risk is the central fundamental caveat. Debt-to-equity stands at 11.70x with a current ratio of 0.818 and a quick ratio of 0.470, reflecting a very thin equity base relative to liabilities; total debt to capitalization of 88.5% and a company equity multiplier of 17.86x confirm the leverage. Free cash flow is nonetheless robust at $684.9 million TTM, with Q2 2026 free cash flow of $84.1 million after $173.8 million of capital expenditure, and operating cash flow of $257.9 million — enough to cover the $15.6 million quarterly dividend and $20 million of buybacks, though the dividend payout ratio of -2.72 and dividend yield of 3.44% reflect a payout that is only sustainable if margins hold. ROE of -7.96% and ROA of 5.49% show the trailing twelve months still carry the weight of the 2025 losses, and with cash of $628.6 million against heavy debt service (Q2 interest expense of $100.1 million), the company depends on continued margin strength to delever rather than on internally generated cash alone.
Quarterly Revenue
$4.1B
2026-06
Revenue YoY Growth
+47.8%
YoY Comparison
Gross Margin
8.9%
Latest Quarter
Free Cash Flow
$684900000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is DK Overvalued?
Because trailing net income is negative (EPS of -$0.0127 and a trailing PE of -78.05x), the PE ratio is not a meaningful primary metric; I therefore lead with the price-to-sales ratio of 0.168x and the EV/sales multiple of 0.643x, both of which are appropriate for a low-margin, high-turnover refiner. The forward PE of 8.02x against the negative trailing PE implies the market expects a sharp earnings normalization — consensus forward EPS is positive even as the trailing figure is negative — and the PEG ratio of 0.816 suggests the growth embedded in that forward estimate is being priced at a discount. The gap between the meaningless trailing multiple and the 8.02x forward multiple is the entire valuation story: investors are paying for the recovery, not the past.
On a peer basis, the 0.168x PS ratio and 0.643x EV/sales are low in absolute terms but consistent with the refining industry's thin-margin economics, where revenue is a poor proxy for value; the more telling comparison is the EV/EBITDA of 5.79x, which sits at a modest discount to the mid-single-digit to high-single-digit range typical of independent refiners and implies the market is not extrapolating the Q2 EBITDA run-rate. The price-to-book of 6.28x is elevated, but that is an artifact of the razor-thin equity base (debt-to-equity of 11.70x) rather than a premium multiple on tangible value. On balance, the stock screens as inexpensive on cash-flow and EBITDA metrics and expensive only on book value — a profile consistent with a leveraged cyclical whose equity is a call option on crack spreads.
Historically, the valuation has compressed dramatically: the PS ratio was 0.762x at Q2 2026 and 1.024x at Q1 2026, versus the current 0.168x, while the PE ratio swung from 4.60x in Q2 2026 to negative territory as earnings rolled off. The stock's own historical PE band has been wildly unstable — ranging from 2.75x in Q3 2025 to -78x today — which makes the PE band nearly useless as an anchor and reinforces the case for EV/EBITDA and PS as the relevant yardsticks. At 0.168x sales, the stock is near the low end of its own multi-year PS range even after a 132% one-year rally, suggesting the market is pricing in mean reversion of margins rather than extrapolating the Q2 peak — a setup that offers upside if crack spreads hold but leaves little margin of safety if they compress.
PE
-78.1x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 1x~28x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
5.8x
Enterprise Value Multiple
Investment Risk Disclosure
Delek's financial risk is dominated by its highly leveraged balance sheet. Debt-to-equity stands at 11.70x, total debt-to-capitalization at 88.5%, and the current ratio is a thin 0.818, while the quick ratio of 0.470 indicates limited liquid assets relative to liabilities. Interest expense of $100.1 million in Q2 2026 consumes a significant portion of operating income ($302.4 million), leaving little room for error if margins compress. The dividend payout ratio of -2.72 (based on negative trailing EPS) and a 3.44% yield are only sustainable if refining margins remain elevated; any downturn could force a cut. Additionally, revenue is heavily concentrated in the refining segment ($4.056 billion of $4.087 billion in Q2 2026), making the top line highly sensitive to crack spreads and throughput volumes. Trailing net margin is still -0.21% and ROE is -7.96%, reflecting the weight of prior losses and the cyclicality of earnings.
Market and competitive risks are significant given the stock's recent parabolic run. The shares have gained 131.95% over the past year and 157.19% YTD, massively outperforming the S&P 500's 15.53% and 11.93% returns, and now trade at 90.1% of the 52-week range. This leaves little margin of safety and exposes the stock to valuation compression if margin momentum stalls. The beta of 0.602 suggests lower market correlation, but the stock is still vulnerable to sector rotation and commodity price swings. Recent news highlights event-driven gains, such as the competitor refinery fire that boosted jet fuel margins, but such tailwinds are transient. The wide analyst target range of $58 to $97 (a 67% spread) underscores disagreement about margin sustainability, and the absence of recent upgrades suggests a holding pattern. Regulatory risks, including environmental compliance and potential changes to biofuel mandates, could also impact refining economics.
The worst-case scenario involves a sharp normalization of crack spreads, triggered by demand destruction or a surge in global refining capacity, which would rapidly erode Delek's margins and cash flow. Given the high leverage, this could lead to covenant pressure, dividend suspension, and a sharp equity de-rating. The 52-week low of $25.85 represents a 66.2% decline from the current $76.59, while the analyst low target of $58 implies a 24.3% downside. A realistic bear case might see the stock retrace to the August consolidation lows around $59.75 (a 22.0% drop) or toward the $58 low target. If margins revert to Q1 2026 levels, when gross margin was -2.66%, the equity could test the $50s. The maximum drawdown of -36.02% over the measured period illustrates the potential magnitude of a downturn.
FAQ
The most severe risk is financial: debt-to-equity of 11.70x and a current ratio of 0.818 create liquidity risk if margins decline. Second is margin cyclicality: gross margin swung from -2.66% to 8.93% in one quarter, and a reversion could quickly erode earnings. Third is valuation risk: after a 132% rally, the stock is near its 52-week high and vulnerable to profit-taking or a momentum reversal. Fourth is regulatory and operational risk, including environmental compliance and unplanned outages. These risks are magnified by the stock's -36.02% max drawdown, indicating potential for sharp losses.
Our 12-month forecast has three scenarios: bull (25% probability) targeting $90-97 if margins remain elevated and leverage decreases; base (50% probability) targeting $75-85 as margins moderate but stay healthy; and bear (25% probability) targeting $58-65 if crack spreads compress and liquidity concerns arise. The base case is most likely, assuming crack spreads normalize but remain above 2025 lows. Key catalysts include quarterly earnings, margin trends, and debt reduction progress. The wide analyst target range of $58 to $97 reflects significant uncertainty.
On cash flow metrics, DK appears undervalued: EV/EBITDA of 5.79x and forward PE of 8.02x are below the broader market and at the low end of its historical range. However, the PS ratio of 0.168x is near multi-year lows, reflecting the market's skepticism about margin sustainability. The price-to-book of 6.28x is elevated due to the thin equity base, making it less relevant. Overall, the stock is fairly valued to slightly undervalued relative to its earnings potential, but the high leverage and cyclicality warrant a discount. The market is pricing in a moderation of margins from Q2 peaks, not a collapse.
DK is a high-risk, high-reward cyclical stock that may appeal to investors with a strong stomach for volatility. The stock has already rallied 132% over the past year and trades near its 52-week high, leaving only 5.4% upside to the average analyst target of $80.69. The bull case rests on sustained refining margins and free cash flow of $684.9 million TTM, while the bear case highlights debt-to-equity of 11.70x and a current ratio of 0.818. For risk-tolerant investors, a small position could be justified if margins remain strong, but conservative investors should wait for a pullback or clearer deleveraging progress.
DK is more suitable for short- to medium-term tactical trading than long-term holding due to its cyclical earnings and high leverage. The stock's beta of 0.602 suggests lower market correlation, but its volatility is driven by commodity spreads, which can change rapidly. The dividend yield of 3.44% is attractive but not secure given the negative payout ratio. Earnings visibility is low, with analyst EPS estimates ranging from -$0.25 to -$0.15 for the current year. A suggested holding period is 6-12 months, with active monitoring of margin trends and balance sheet metrics. Long-term investors may prefer larger, less leveraged refiners.